Transaction #2701 · Form 4 · 0001864485-25-000005
Rani Therapeutics Holdings, Inc. · Stock award · Stock Option (Right to Buy)
Rani Therapeutics Holdings, Inc. · Transacted October 23, 2025 · Filed October 27, 2025
What does this filing report?
An SEC Form 4 filing for Rani Therapeutics Holdings, Inc. records a stock award involving Stock Option (Right to Buy) on October 23, 2025. The reported quantity was 100,000. The filing date is October 27, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0001856725
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 100,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 100,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 27, 2025, 7:29 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Bassan Abraham ↗
Director
CIK 0001864485
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Class A Common Stock
- Underlying quantity
- 100,000
- Conversion / exercise price
- 2.09
- Exercise date
- Not reported
- Expiration date
- October 22, 2035
Filing footnotes & remarks
- F1
- The shares subject to this option will vest over a three-year period, with one-third of the shares subject to the option vesting on October 23, 2026, and one thirty-sixth of the shares subject to the option vesting each month thereafter, subject to the Reporting Person's continuous service with the Company through each vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.